Study of hemostatic biomarkers in acute ischemic stroke by clinical subtype

Journal of Stroke and Cerebrovascular Diseases

Volumn 21, Issue 5, 2012, Pages 404-410

  Hirano, Koji ^a   Takashima, Shutaro ^a   Dougu, Nobuhiro ^a   Taguchi, Yoshiharu ^a   Nukui, Takamasa ^a   Konishi, Hirohumi ^a   Toyoda, Shigeo ^a   Kitajima, Isao ^b   Tanaka, Kortaro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Biomarkers; D dimer; fibrin monomer complex; ischemic stroke; soluble fibrin

Indexed keywords

ANTITHROMBIN III; BIOLOGICAL MARKER; D DIMER; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRIN MONOMER; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; THROMBIN ANTITHROMBIN COMPLEX;

ACUTE BRAIN DISEASE; AGED; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RANKIN SCALE; STROKE PATIENT; THROMBOGENESIS;

ANTITHROMBIN III; BIOLOGICAL MARKERS; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEMOSTASIS; HUMANS; INTRACRANIAL THROMBOSIS; MALE; PROGNOSIS; STROKE;

EID: 84862854240     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2011.08.013     Document Type: Article

References (21)

1. Hanzawa K, Hayashi J, Kitajima I, et al. Venous thrombois and hemostatic biomarkers in the Mid-Niigata prefecture earthquake. Therapeutic Research 2006;27:971-975.
2. Kubo T, Kitajima I, Makinodan A, et al. Fibrin monomer could be a useful predictor of pulmonary embolism after total hip arthroplasty: Preliminary report. J Orthop Sci 2001;6:119-122. (Pubitemid 32367598)
3. Ieko M, Nakabayashi T, Tarumi T, et al. Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis. Clin Chim Acta 2007;386:38-48.
4. Ota S, Wada H, Nobori T, et al. Diagnosis of deep vein thrombosis by plasma-soluble fibrin or D-dimer. Am J Hematol 2005;79:274-280. (Pubitemid 41098839)
5. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990;21:637-676.
6. Takano K, Yanaguchi T, Kato H, et al. Activation of coagulation in acute cardioembolic stroke. Stroke 1991;22:12-16.
7. Berge E, Friis P, Sandset PM. Hemostastic activation in acute ischemic stroke. Thromb Res 2001;101:13-21. (Pubitemid 32141176)
8. Feinberg WM, Brunk DC, Ring ME, et al. Hemostastic markers in acute stroke. Stroke 1989;20:592-597.
9. Koch HJ, Horn M, Bogdahn U, et al. The relationship between plasma D-dimer concentrations and acute ischemic stroke subtypes. J Stroke Cerebrovasc Dis 2005; 14:75-79. (Pubitemid 40332497)
10. Dougu N, Takashima S, Sasahara E, et al. Differential diagnosis of cerebral infarction using an algorithm combining atrial fibrillation and D-dimer level. Eur J Neurol 2008;15:295-300. (Pubitemid 351257933)
11. Ageno W, Finazzi S, Steidl L, et al. Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes. Arch Intern Med 2002;162:2589-2593. (Pubitemid 35453498)
12. Okuyama H, Hirono O, Liu L, et al. Higher levels of serum fibrin-monomer reflect hypercoagulable state and thrombus formation in the left atrial appendage in patients with acute ischemic stroke. Circ J 2006;70:971-976. (Pubitemid 44161731)
13. Tamura H, Hirono O, Okuyama H, et al. Elevated serum fibrin-monomer levels are associated with high long-term cerebrovascular event rates in acute ischemic stroke patients. Circ J 2007;71:1573-1579. (Pubitemid 47529659)
14. Tanne D, Benderly M, Goldbourt U, et al. A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study. Am J Med 2001;111:457-463. (Pubitemid 33016417)
15. Yamaguchi K, Kitajima I. Hemostatic biomarkers in acute thrombosis, fibrin monomer complex. Assay and Technology 2005;33:785-787.
16. Mitusch R, Siemens HJ, Garbe M, et al. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy. Thromb Haemost 1996;75:219-223. (Pubitemid 26081470)
17. Barber M, Langhorne P, Rumley A, et al. Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression. Stroke 2004;35:1421-1425. (Pubitemid 38697469)
18. Squizzato A, Ageno W, Finazzi S, et al. D-dimer is not a long-term prognostic marker following acute cerebral ischemia. Fibrinolysis 2006;17:303-306.
19. Rallidis LS, Vikelis M, Panagiotakos DB, et al. Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients. Acta Neurol Scand 2008;117:415-420. (Pubitemid 351643673)
20. Nozawa T, Inoue H, Hirai T, et al. D-dimer level influences thromboembolic events in patients with atrial fibrillation. Int J Cardiol 2006;109:59-65.
21. Whiteley W, Chong WL, Sengupta A, et al. Blood markers for the prognosis of ischemic stroke: A systematic review. Stroke 2009;40:e380-e389.